Stay updated on Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Prasinezumab in Early Parkinson's Disease Clinical Trial page
- CheckyesterdayChange DetectedRecord history now displays a dedicated Study Status entry for the latest version (v58, 2026-09-09), reflecting current status updates, and an older entry from 2026-07-13 was deleted.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page history now shows a new revision label (v3.6.6) replacing the previous v3.6.5. This indicates a latest update to the study record without altering core content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe history now shows Revision: v3.6.5, indicating a newer page revision. This is a maintenance/metadata update rather than a substantive change to the study data or its description.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating a software update to the ClinicalTrials.gov site.SummaryDifference0.0%

- Check58 days agoChange DetectedCore trial data sections were added to the study record history on 2026-07-13, including Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Arms and Interventions, and Study Status. A deletion was recorded on 2026-03-17.SummaryDifference0.5%

- Check72 days agoChange DetectedThe page history now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor release/update to the page's build metadata.SummaryDifference0.1%

Stay in the know with updates to Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.